StartUp Health NOW Podcast Rethinking the Rules: Julie Yoo of a16z on Infinite Healthcare, Compound Businesses, and the New Investor Playbook
Apr 10, 2026
Julie Yoo, General Partner at a16z and former Kyruus co-founder who scaled care access to millions, discusses why AI is transforming healthcare now. She explains the rise of compound business models and what investors seek at Series A. The conversation covers integration challenges, payment model ideas for 'infinite' care, and how founders can seize this moment.
AI Snips
Chapters
Transcript
Episode notes
Health Tech Metrics Now Look Like Tech Companies
- Health tech companies today show growth and unit economics that look much more like traditional tech than past digital health firms.
- Julie Yoo says enterprise and consumer partners now actively seek health deals because on-paper metrics have improved.
Consider Compound Business Models Now
- Do consider building compound businesses that sell multiple products or business models simultaneously when AI lowers the cost of core infrastructure.
- Julie Yoo admits she once advised against this but now sees portfolio companies succeed by parallelizing revenue streams via AI leverage.
Win Investors With Founder Exceptionalism
- Focus investor evaluation on founder quality, roadmap ambition, and five-year vision because many Series A companies now look similar on metrics.
- Julie Yoo warns that standardized Series A numbers force investors to judge exceptionalism in team and long-term product plans.